newsfilter
← Latest News
Business Wire·

Innoviva Specialty Therapeutics' Antimicrobial Therapies ZEVTERA® and XACDURO® Nominated for the 2025 Prix Galien USA Best Pharmaceutical Product Award

Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ:INVA), announced today that two of the company's infectious disease therapies, ZEVTERA® (ceftobiprole medocaril sodium for injection) and